Related Experiment Video
Updated: Aug 27, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
Zijun Wang1, Pengcheng Zhou1, Frauke Muecksch2
1Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.
Abstract:
Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough infections on memory responses. Here, we examine the memory antibodies that develop after a third or fourth antigenic exposure by Delta or Omicron BA.1 infection, respectively. A third exposure to antigen by Delta breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a third mRNA vaccine dose. A fourth antigenic exposure with Omicron BA.1 infection increased variant-specific plasma antibody and memory B cell responses. However, the fourth exposure did not increase the overall frequency of memory B cells or their general potency or breadth compared to a third mRNA vaccine dose. In conclusion, a third antigenic exposure by Delta infection elicits strain-specific memory responses and increases in the overall potency and breadth of the memory B cells. In contrast, the effects of a fourth antigenic exposure with Omicron BA.1 are limited to increased strain-specific memory with little effect on the potency or breadth of memory B cell antibodies. The results suggest that the effect of strain-specific boosting on memory B cell compartment may be limited.
Insights
A third COVID-19 vaccine dose boosts protection. Breakthrough infections after a third dose (Delta) enhance memory B cells, but a fourth dose (Omicron BA.1) offers limited additional benefits.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- A third mRNA vaccine dose enhances protection against severe COVID-19.
- The impact of breakthrough infections on immune memory responses remains understudied.
Purpose of the Study:
- To investigate the impact of breakthrough infections on memory antibody responses after a third or fourth antigenic exposure.
- To compare the effects of Delta and Omicron BA.1 infections on B cell memory.
Main Methods:
- Analysis of memory B cell responses following third (Delta) and fourth (Omicron BA.1) antigenic exposures.
- Assessment of antibody potency and breadth.
Main Results:
- A third antigenic exposure via Delta breakthrough infection increased memory B cells with antibody potency and breadth comparable to a third mRNA vaccine dose.
- A fourth antigenic exposure via Omicron BA.1 infection boosted variant-specific antibodies and memory B cells but did not enhance overall memory cell frequency, potency, or breadth.
- The fourth exposure's effects were limited to increased Omicron BA.1-specific memory.
Conclusions:
- A third antigenic exposure, particularly by Delta infection, elicits strain-specific memory responses and broadens the potency of memory B cells.
- A fourth antigenic exposure with Omicron BA.1 infection primarily increases strain-specific memory with minimal impact on the overall potency or breadth of memory B cell antibodies.
- Strain-specific boosting may have limited effects on the broader memory B cell compartment.
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Cells of the Adaptive Immune Response
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cross-reactivity
Vaccinations
Humoral Immune Responses

